Cas No.: | 1613695-14-9 |
Chemical Name: | Sgc-cbp30 |
Synonyms: | SGC-CBP30;(s)-4-(1-(2-(3-chloro-4-methoxyphenethyl)-5-(3,5-dimethylisoxazol-4-yl)-1h-benzo[d]imidazol-1-yl)propan-2-yl)morpholine;2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benzodiazole;2-[2-(3-Chloro-4-Methoxyphenyl)ethyl]-5-(3,5-Dimethyl-1,2-Oxazol-4-Yl)-1-[(2s)-2-(Morpholin-4-Yl)propyl]-1h-Benzimidazole;2LO;C28H33ClN4O3;GTPL7529;AOB4800;BDBM188519;s725 |
SMILES: | ClC1=C(C=CC(=C1)CCC1=NC2C=C(C3C(C)=NOC=3C)C=CC=2N1C[C@H](C)N1CCOCC1)OC |
Formula: | C28H33ClN4O3 |
M.Wt: | 509.0396 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | As a CREBBP/EP300-selective chemical probe, SGC-CBP30 shows moderate cytotoxicity in U2OS cells and HeLa cells.For the detailed information of SGC-CBP30, the solubility of SGC-CBP30 in water, the solubility of SGC-CBP30 in DMSO, the solubility of SGC-CBP30 in PBS buffer, the animal experiment (test) of SGC-CBP30, the cell expriment (test) of SGC-CBP30, the in vivo, in vitro and clinical trial test of SGC-CBP30, the EC50, IC50,and Affinity of SGC-CBP30, Please contact DC Chemicals. |